ONCYs Offering to continue advancement of clinical progamsThe Company intends to use the proceeds from the Offering to continue the advancement of its pelareorep clinical programs in metastatic breast and pancreatic cancers.
https://www.oncolyticsbiotech.com/press-releases/detail/606/oncolytics-biotech-successfully-raises-us15-million-to